Dupont Capital Management’s Albany Molecular Research Inc AMRI Stock Holding History

Dupont Capital Management’s Portfolio AMRI Stock Details AMRI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-98,208	Closed	-$2.13M	–	1024
2017 Q2	$2.13M	Buy	+98,208	New	+$1.78M	0.05%	343

Other funds holding AMRI

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Dupont Capital Management's AMRI Position: Q3 2017 in Review

Dupont Capital Management sold out of Albany Molecular Research Inc (AMRI) in Q3 2017, closing a stake of 98,208 shares — an estimated $2.13M sold.

Dupont Capital Management first reported a position in AMRI in Q2 2017 and held it in 1 quarter. The position peaked at $2.13M in Q2 2017. 2 funds tracked by Wall St. Rank hold AMRI as of Q3 2017.

Dupont Capital Management reported no remaining Albany Molecular Research Inc position as of Q3 2017 after selling out during the quarter.
Dupont Capital Management sold 98,208 Albany Molecular Research Inc shares in Q3 2017, an estimated $2.13M.
Dupont Capital Management first reported a position in Albany Molecular Research Inc in Q2 2017 and held it in 1 quarter.
Dupont Capital Management's Albany Molecular Research Inc position peaked at $2.13M in Q2 2017.
2 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q3 2017.

Based on Dupont Capital Management's 13F filing for Q3 2017, filed 31 Oct 2017.